**Core Concept:** The question is asking about the most sensitive test to diagnose immune-mediated necrotizing myopathy (IMN), which is a rare autoimmune disorder characterized by muscle weakness and elevated creatine kinase levels. IMN is typically associated with serum anti-HMGCR autoantibodies.

**Why the Correct Answer is Right:** The correct answer, **Option D**, refers to the measurement of serum anti-HMGCR autoantibodies. These autoantibodies are highly specific and sensitive in diagnosing IMN, as they target enzymes involved in cholesterol synthesis, leading to muscle necrosis and inflammation. Elevated creatine kinase levels are a common feature in IMN, but the presence of anti-HMGCR autoantibodies is more definitive for diagnosis.

**Why Each Wrong Option is Incorrect:**

**A.** **Option A (serum creatine kinase levels):** While elevated creatine kinase levels are a hallmark of IMN, they are nonspecific and can be seen in other conditions like rhabdomyolysis or malignant hyperthermia. Merely elevated CK levels do not confirm IMN diagnosis.

**B.** **Option B (electromyography):** Electromyography (EMG) is useful in evaluating neuromuscular disorders, but it provides information about muscle innervation and not the presence of autoantibodies or direct evidence of muscle necrosis.

**C.** **Option C (muscle biopsy):** A muscle biopsy can show necrotic muscle fibers and inflammation, but it is an invasive procedure with potential complications and may not always be feasible due to the location of the affected muscle. Additionally, it does not provide information about the presence of autoantibodies like anti-HMGCR.

**Clinical Pearl:** In clinical practice, a combination of elevated CK levels and the presence of anti-HMGCR autoantibodies is essential to confirm the diagnosis of IMN, ensuring a comprehensive and accurate diagnosis.

**Correct Answer:** **Option D (serum anti-HMGCR autoantibodies)** is the most sensitive and specific test to diagnose IMN. The presence of these autoantibodies confirms the diagnosis, as they target enzymes involved in cholesterol synthesis leading to muscle necrosis and inflammation. Elevated creatine kinase levels (Option A) and necrotic muscle changes on biopsy (Option C) are supportive findings but lack specificity without the presence of anti-HMGCR autoantibodies. EMG (Option B) provides information about muscle innervation but not the presence of autoantibodies.